Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 76 Leukemia, Myeloid, Acute 68 Prostatic Neoplasms 66 Carcinoma, Non-Small-Cell Lung 56 Neoplasm Metastasis 55 Breast Neoplasms 50 Multiple Myeloma 42 Colorectal Neoplasms 40 Pancreatic Neoplasms 33 Carcinoma, Renal Cell 32 Myelodysplastic Syndromes 31 Melanoma 31 Leukemia, Lymphocytic, Chronic, B-Cell 29 Triple Negative Breast Neoplasms 28 Ovarian Neoplasms 27 Lymphoma, Large B-Cell, Diffuse 25 Glioblastoma 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Urinary Bladder Neoplasms 22 Lymphoma 22 Burkitt Lymphoma 21 Squamous Cell Carcinoma of Head and Neck 20 Carcinoma, Hepatocellular 19 Glioma 18 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 17 Oropharyngeal Neoplasms 15 Mouth Neoplasms 15 Lymphoma, Follicular 15 Leukemia, Biphenotypic, Acute 15

Interventions

regorafenib 1 beta-Aminoethyl Isothiourea 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Self Care 1 Ocoxin 1 Nutrition Assessment 1 Motivational Interviewing 1 Leuprolide 1 Goserelin 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Specimen Handling × 1 year × Clear all

NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡